2018-2023 Global CINV Existing and Pipeline Drugs Consumption Market Report

October 2018 | 135 pages | ID: 238100F9787EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global CINV Existing and Pipeline Drugs market for 2018-2023.
Nausea and vomiting are the two most common side effects associated with cancer chemotherapy, and are referred to as chemotherapy induced nausea and vomiting (CINV).

Over the next five years, LPI(LP Information) projects that CINV Existing and Pipeline Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of CINV Existing and Pipeline Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Aloxi (palonosetron)
• Zofran Generic (ondansetron)
• Kytril Generic (granisetron)
• Emend (aprepitant)
• Akynzeo (netupitant-palonosetron)
• SUSTOL (extended release granisetron injection)
• Rolapitant

Segmentation by application:

• Hospitals
• Specialty Clinics
• Diagnostic Centers Therapeutics
• Hospital Pharmacies
• Drugstores

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• GlaxoSmithKline
• Helsinn
• Heron Therapeutics
• Merck
• Tesaro

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global CINV Existing and Pipeline Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of CINV Existing and Pipeline Drugs market by identifying its various subsegments.
• Focuses on the key global CINV Existing and Pipeline Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the CINV Existing and Pipeline Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of CINV Existing and Pipeline Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL CINV EXISTING AND PIPELINE DRUGS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global CINV Existing and Pipeline Drugs Consumption 2013-2023
  2.1.2 CINV Existing and Pipeline Drugs Consumption CAGR by Region
2.2 CINV Existing and Pipeline Drugs Segment by Type
  2.2.1 Aloxi (palonosetron)
  2.2.2 Zofran Generic (ondansetron)
  2.2.3 Kytril Generic (granisetron)
  2.2.4 Emend (aprepitant)
  2.2.5 Akynzeo (netupitant-palonosetron)
  2.2.6 SUSTOL (extended release granisetron injection)
  2.2.7 Rolapitant
2.3 CINV Existing and Pipeline Drugs Consumption by Type
  2.3.1 Global CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global CINV Existing and Pipeline Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global CINV Existing and Pipeline Drugs Sale Price by Type (2013-2018)
2.4 CINV Existing and Pipeline Drugs Segment by Application
  2.4.1 Hospitals
  2.4.2 Specialty Clinics
  2.4.3 Diagnostic Centers Therapeutics
  2.4.4 Hospital Pharmacies
  2.4.5 Drugstores
2.5 CINV Existing and Pipeline Drugs Consumption by Application
  2.5.1 Global CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global CINV Existing and Pipeline Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global CINV Existing and Pipeline Drugs Sale Price by Application (2013-2018)

3 GLOBAL CINV EXISTING AND PIPELINE DRUGS BY PLAYERS

3.1 Global CINV Existing and Pipeline Drugs Sales Market Share by Players
  3.1.1 Global CINV Existing and Pipeline Drugs Sales by Players (2016-2018)
  3.1.2 Global CINV Existing and Pipeline Drugs Sales Market Share by Players (2016-2018)
3.2 Global CINV Existing and Pipeline Drugs Revenue Market Share by Players
  3.2.1 Global CINV Existing and Pipeline Drugs Revenue by Players (2016-2018)
  3.2.2 Global CINV Existing and Pipeline Drugs Revenue Market Share by Players (2016-2018)
3.3 Global CINV Existing and Pipeline Drugs Sale Price by Players
3.4 Global CINV Existing and Pipeline Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global CINV Existing and Pipeline Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players CINV Existing and Pipeline Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 CINV EXISTING AND PIPELINE DRUGS BY REGIONS

4.1 CINV Existing and Pipeline Drugs by Regions
  4.1.1 Global CINV Existing and Pipeline Drugs Consumption by Regions
  4.1.2 Global CINV Existing and Pipeline Drugs Value by Regions
4.2 Americas CINV Existing and Pipeline Drugs Consumption Growth
4.3 APAC CINV Existing and Pipeline Drugs Consumption Growth
4.4 Europe CINV Existing and Pipeline Drugs Consumption Growth
4.5 Middle East & Africa CINV Existing and Pipeline Drugs Consumption Growth

5 AMERICAS

5.1 Americas CINV Existing and Pipeline Drugs Consumption by Countries
  5.1.1 Americas CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas CINV Existing and Pipeline Drugs Value by Countries (2013-2018)
5.2 Americas CINV Existing and Pipeline Drugs Consumption by Type
5.3 Americas CINV Existing and Pipeline Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC CINV Existing and Pipeline Drugs Consumption by Countries
  6.1.1 APAC CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC CINV Existing and Pipeline Drugs Value by Countries (2013-2018)
6.2 APAC CINV Existing and Pipeline Drugs Consumption by Type
6.3 APAC CINV Existing and Pipeline Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe CINV Existing and Pipeline Drugs by Countries
  7.1.1 Europe CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe CINV Existing and Pipeline Drugs Value by Countries (2013-2018)
7.2 Europe CINV Existing and Pipeline Drugs Consumption by Type
7.3 Europe CINV Existing and Pipeline Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa CINV Existing and Pipeline Drugs by Countries
  8.1.1 Middle East & Africa CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa CINV Existing and Pipeline Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa CINV Existing and Pipeline Drugs Consumption by Type
8.3 Middle East & Africa CINV Existing and Pipeline Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 CINV Existing and Pipeline Drugs Distributors
10.3 CINV Existing and Pipeline Drugs Customer

11 GLOBAL CINV EXISTING AND PIPELINE DRUGS MARKET FORECAST

11.1 Global CINV Existing and Pipeline Drugs Consumption Forecast (2018-2023)
11.2 Global CINV Existing and Pipeline Drugs Forecast by Regions
  11.2.1 Global CINV Existing and Pipeline Drugs Forecast by Regions (2018-2023)
  11.2.2 Global CINV Existing and Pipeline Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global CINV Existing and Pipeline Drugs Forecast by Type
11.8 Global CINV Existing and Pipeline Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 GlaxoSmithKline
  12.1.1 Company Details
  12.1.2 CINV Existing and Pipeline Drugs Product Offered
  12.1.3 GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 GlaxoSmithKline News
12.2 Helsinn
  12.2.1 Company Details
  12.2.2 CINV Existing and Pipeline Drugs Product Offered
  12.2.3 Helsinn CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Helsinn News
12.3 Heron Therapeutics
  12.3.1 Company Details
  12.3.2 CINV Existing and Pipeline Drugs Product Offered
  12.3.3 Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Heron Therapeutics News
12.4 Merck
  12.4.1 Company Details
  12.4.2 CINV Existing and Pipeline Drugs Product Offered
  12.4.3 Merck CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Merck News
12.5 Tesaro
  12.5.1 Company Details
  12.5.2 CINV Existing and Pipeline Drugs Product Offered
  12.5.3 Tesaro CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Tesaro News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of CINV Existing and Pipeline Drugs
Table Product Specifications of CINV Existing and Pipeline Drugs
Figure CINV Existing and Pipeline Drugs Report Years Considered
Figure Market Research Methodology
Figure Global CINV Existing and Pipeline Drugs Consumption Growth Rate 2013-2023 (Kg)
Figure Global CINV Existing and Pipeline Drugs Value Growth Rate 2013-2023 ($ Millions)
Table CINV Existing and Pipeline Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Aloxi (palonosetron)
Table Major Players of Aloxi (palonosetron)
Figure Product Picture of Zofran Generic (ondansetron)
Table Major Players of Zofran Generic (ondansetron)
Figure Product Picture of Kytril Generic (granisetron)
Table Major Players of Kytril Generic (granisetron)
Figure Product Picture of Emend (aprepitant)
Table Major Players of Emend (aprepitant)
Figure Product Picture of Akynzeo (netupitant-palonosetron)
Table Major Players of Akynzeo (netupitant-palonosetron)
Figure Product Picture of SUSTOL (extended release granisetron injection)
Table Major Players of SUSTOL (extended release granisetron injection)
Figure Product Picture of Rolapitant
Table Major Players of Rolapitant
Table Global Consumption Sales by Type (2013-2018)
Table Global CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
Figure Global CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
Table Global CINV Existing and Pipeline Drugs Revenue by Type (2013-2018) ($ million)
Table Global CINV Existing and Pipeline Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global CINV Existing and Pipeline Drugs Value Market Share by Type (2013-2018)
Table Global CINV Existing and Pipeline Drugs Sale Price by Type (2013-2018)
Figure CINV Existing and Pipeline Drugs Consumed in Hospitals
Figure Global CINV Existing and Pipeline Drugs Market: Hospitals (2013-2018) (Kg)
Figure Global CINV Existing and Pipeline Drugs Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure CINV Existing and Pipeline Drugs Consumed in Specialty Clinics
Figure Global CINV Existing and Pipeline Drugs Market: Specialty Clinics (2013-2018) (Kg)
Figure Global CINV Existing and Pipeline Drugs Market: Specialty Clinics (2013-2018) ($ Millions)
Figure Global Specialty Clinics YoY Growth ($ Millions)
Figure CINV Existing and Pipeline Drugs Consumed in Diagnostic Centers Therapeutics
Figure Global CINV Existing and Pipeline Drugs Market: Diagnostic Centers Therapeutics (2013-2018) (Kg)
Figure Global CINV Existing and Pipeline Drugs Market: Diagnostic Centers Therapeutics (2013-2018) ($ Millions)
Figure Global Diagnostic Centers Therapeutics YoY Growth ($ Millions)
Figure CINV Existing and Pipeline Drugs Consumed in Hospital Pharmacies
Figure Global CINV Existing and Pipeline Drugs Market: Hospital Pharmacies (2013-2018) (Kg)
Figure Global CINV Existing and Pipeline Drugs Market: Hospital Pharmacies (2013-2018) ($ Millions)
Figure Global Hospital Pharmacies YoY Growth ($ Millions)
Figure CINV Existing and Pipeline Drugs Consumed in Drugstores
Figure Global CINV Existing and Pipeline Drugs Market: Drugstores (2013-2018) (Kg)
Figure Global CINV Existing and Pipeline Drugs Market: Drugstores (2013-2018) ($ Millions)
Figure Global Drugstores YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
Figure Global CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
Table Global CINV Existing and Pipeline Drugs Value by Application (2013-2018)
Table Global CINV Existing and Pipeline Drugs Value Market Share by Application (2013-2018)
Figure Global CINV Existing and Pipeline Drugs Value Market Share by Application (2013-2018)
Table Global CINV Existing and Pipeline Drugs Sale Price by Application (2013-2018)
Table Global CINV Existing and Pipeline Drugs Sales by Players (2016-2018) (Kg)
Table Global CINV Existing and Pipeline Drugs Sales Market Share by Players (2016-2018)
Figure Global CINV Existing and Pipeline Drugs Sales Market Share by Players in 2016
Figure Global CINV Existing and Pipeline Drugs Sales Market Share by Players in 2017
Table Global CINV Existing and Pipeline Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global CINV Existing and Pipeline Drugs Revenue Market Share by Players (2016-2018)
Figure Global CINV Existing and Pipeline Drugs Revenue Market Share by Players in 2016
Figure Global CINV Existing and Pipeline Drugs Revenue Market Share by Players in 2017
Table Global CINV Existing and Pipeline Drugs Sale Price by Players (2016-2018)
Figure Global CINV Existing and Pipeline Drugs Sale Price by Players in 2017
Table Global CINV Existing and Pipeline Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players CINV Existing and Pipeline Drugs Products Offered
Table CINV Existing and Pipeline Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global CINV Existing and Pipeline Drugs Consumption by Regions 2013-2018 (Kg)
Table Global CINV Existing and Pipeline Drugs Consumption Market Share by Regions 2013-2018
Figure Global CINV Existing and Pipeline Drugs Consumption Market Share by Regions 2013-2018
Table Global CINV Existing and Pipeline Drugs Value by Regions 2013-2018 ($ Millions)
Table Global CINV Existing and Pipeline Drugs Value Market Share by Regions 2013-2018
Figure Global CINV Existing and Pipeline Drugs Value Market Share by Regions 2013-2018
Figure Americas CINV Existing and Pipeline Drugs Consumption 2013-2018 (Kg)
Figure Americas CINV Existing and Pipeline Drugs Value 2013-2018 ($ Millions)
Figure APAC CINV Existing and Pipeline Drugs Consumption 2013-2018 (Kg)
Figure APAC CINV Existing and Pipeline Drugs Value 2013-2018 ($ Millions)
Figure Europe CINV Existing and Pipeline Drugs Consumption 2013-2018 (Kg)
Figure Europe CINV Existing and Pipeline Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Consumption 2013-2018 (Kg)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Value 2013-2018 ($ Millions)
Table Americas CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018) (Kg)
Table Americas CINV Existing and Pipeline Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas CINV Existing and Pipeline Drugs Consumption Market Share by Countries in 2017
Table Americas CINV Existing and Pipeline Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas CINV Existing and Pipeline Drugs Value Market Share by Countries (2013-2018)
Figure Americas CINV Existing and Pipeline Drugs Value Market Share by Countries in 2017
Table Americas CINV Existing and Pipeline Drugs Consumption by Type (2013-2018) (Kg)
Table Americas CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
Figure Americas CINV Existing and Pipeline Drugs Consumption Market Share by Type in 2017
Table Americas CINV Existing and Pipeline Drugs Consumption by Application (2013-2018) (Kg)
Table Americas CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
Figure Americas CINV Existing and Pipeline Drugs Consumption Market Share by Application in 2017
Figure United States CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure United States CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Canada CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Mexico CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Table APAC CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018) (Kg)
Table APAC CINV Existing and Pipeline Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC CINV Existing and Pipeline Drugs Consumption Market Share by Countries in 2017
Table APAC CINV Existing and Pipeline Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC CINV Existing and Pipeline Drugs Value Market Share by Countries (2013-2018)
Figure APAC CINV Existing and Pipeline Drugs Value Market Share by Countries in 2017
Table APAC CINV Existing and Pipeline Drugs Consumption by Type (2013-2018) (Kg)
Table APAC CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
Figure APAC CINV Existing and Pipeline Drugs Consumption Market Share by Type in 2017
Table APAC CINV Existing and Pipeline Drugs Consumption by Application (2013-2018) (Kg)
Table APAC CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
Figure APAC CINV Existing and Pipeline Drugs Consumption Market Share by Application in 2017
Figure China CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure China CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Japan CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Korea CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Southeast Asia CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure India CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure India CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Australia CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Table Europe CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018) (Kg)
Table Europe CINV Existing and Pipeline Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe CINV Existing and Pipeline Drugs Consumption Market Share by Countries in 2017
Table Europe CINV Existing and Pipeline Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe CINV Existing and Pipeline Drugs Value Market Share by Countries (2013-2018)
Figure Europe CINV Existing and Pipeline Drugs Value Market Share by Countries in 2017
Table Europe CINV Existing and Pipeline Drugs Consumption by Type (2013-2018) (Kg)
Table Europe CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
Figure Europe CINV Existing and Pipeline Drugs Consumption Market Share by Type in 2017
Table Europe CINV Existing and Pipeline Drugs Consumption by Application (2013-2018) (Kg)
Table Europe CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
Figure Europe CINV Existing and Pipeline Drugs Consumption Market Share by Application in 2017
Figure Germany CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Germany CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure France CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure France CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure UK CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure UK CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Italy CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Russia CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Spain CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa CINV Existing and Pipeline Drugs Consumption by Countries (2013-2018) (Kg)
Table Middle East & Africa CINV Existing and Pipeline Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa CINV Existing and Pipeline Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa CINV Existing and Pipeline Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Value Market Share by Countries in 2017
Table Middle East & Africa CINV Existing and Pipeline Drugs Consumption by Type (2013-2018) (Kg)
Table Middle East & Africa CINV Existing and Pipeline Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa CINV Existing and Pipeline Drugs Consumption by Application (2013-2018) (Kg)
Table Middle East & Africa CINV Existing and Pipeline Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Consumption Market Share by Application in 2017
Figure Egypt CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Egypt CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure South Africa CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Israel CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure Turkey CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries CINV Existing and Pipeline Drugs Consumption Growth 2013-2018 (Kg)
Figure GCC Countries CINV Existing and Pipeline Drugs Value Growth 2013-2018 ($ Millions)
Table CINV Existing and Pipeline Drugs Distributors List
Table CINV Existing and Pipeline Drugs Customer List
Figure Global CINV Existing and Pipeline Drugs Consumption Growth Rate Forecast (2018-2023) (Kg)
Figure Global CINV Existing and Pipeline Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global CINV Existing and Pipeline Drugs Consumption Forecast by Countries (2018-2023) (Kg)
Table Global CINV Existing and Pipeline Drugs Consumption Market Forecast by Regions
Table Global CINV Existing and Pipeline Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global CINV Existing and Pipeline Drugs Value Market Share Forecast by Regions
Figure Americas CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Americas CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure APAC CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure APAC CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Europe CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Europe CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Middle East & Africa CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure United States CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure United States CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Canada CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Canada CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Mexico CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Mexico CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Brazil CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Brazil CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure China CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure China CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Japan CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Japan CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Korea CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Korea CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Southeast Asia CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure India CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure India CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Australia CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Australia CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Germany CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Germany CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure France CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure France CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure UK CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure UK CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Italy CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Italy CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Russia CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Russia CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Spain CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Spain CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Egypt CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Egypt CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure South Africa CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure South Africa CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Israel CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Israel CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure Turkey CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure Turkey CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries CINV Existing and Pipeline Drugs Consumption 2018-2023 (Kg)
Figure GCC Countries CINV Existing and Pipeline Drugs Value 2018-2023 ($ Millions)
Table Global CINV Existing and Pipeline Drugs Consumption Forecast by Type (2018-2023) (Kg)
Table Global CINV Existing and Pipeline Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global CINV Existing and Pipeline Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global CINV Existing and Pipeline Drugs Value Market Share Forecast by Type (2018-2023)
Table Global CINV Existing and Pipeline Drugs Consumption Forecast by Application (2018-2023) (Kg)
Table Global CINV Existing and Pipeline Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global CINV Existing and Pipeline Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global CINV Existing and Pipeline Drugs Value Market Share Forecast by Application (2018-2023)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline CINV Existing and Pipeline Drugs Market Share (2016-2018)
Table Helsinn Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Helsinn CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Helsinn CINV Existing and Pipeline Drugs Market Share (2016-2018)
Table Heron Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heron Therapeutics CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Heron Therapeutics CINV Existing and Pipeline Drugs Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck CINV Existing and Pipeline Drugs Market Share (2016-2018)
Table Tesaro Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Tesaro CINV Existing and Pipeline Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Tesaro CINV Existing and Pipeline Drugs Market Share (2016-2018)